| David Carroll, PSYD, LP | |
|
1751 Tower Dr W Ste 200, Stillwater, MN 55082-7596 | |
| (651) 439-2059 | |
| (888) 675-8262 |
| Full Name | David Carroll |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 19 Years |
| Location | 1751 Tower Dr W Ste 200, Stillwater, Minnesota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205913290 | NPI | - | NPPES |
| 1205913290 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2633 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush Inc | 8224131750 | 6 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record revenue for the fourth quarter and full year 2011, and for the first time, provided initial guidance on management's outlook for the full year 2012.
Conducted by researchers from the Centre for the Study of Health and Society at the University of Melbourne, the study was spurred by observation that the voices and perspectives of those most affected by asbestos disease are rarely heard in the formulation of responses to Australia's on-going asbestos disease epidemic.
While a great deal of research has been conducted on child and adult malnutrition in developing countries, there are only a handful of studies on adolescent malnutrition.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
› Verified 5 days ago
| Entity Name | Rush Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801942040 PECOS PAC ID: 8224131750 Enrollment ID: O20070321000265 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record revenue for the fourth quarter and full year 2011, and for the first time, provided initial guidance on management's outlook for the full year 2012.
Conducted by researchers from the Centre for the Study of Health and Society at the University of Melbourne, the study was spurred by observation that the voices and perspectives of those most affected by asbestos disease are rarely heard in the formulation of responses to Australia's on-going asbestos disease epidemic.
While a great deal of research has been conducted on child and adult malnutrition in developing countries, there are only a handful of studies on adolescent malnutrition.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Carroll, PSYD, LP 588 101st Ave N, Naples, FL 34108-3201 Ph: (651) 439-2059 | David Carroll, PSYD, LP 1751 Tower Dr W Ste 200, Stillwater, MN 55082-7596 Ph: (651) 439-2059 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record revenue for the fourth quarter and full year 2011, and for the first time, provided initial guidance on management's outlook for the full year 2012.
Conducted by researchers from the Centre for the Study of Health and Society at the University of Melbourne, the study was spurred by observation that the voices and perspectives of those most affected by asbestos disease are rarely heard in the formulation of responses to Australia's on-going asbestos disease epidemic.
While a great deal of research has been conducted on child and adult malnutrition in developing countries, there are only a handful of studies on adolescent malnutrition.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
› Verified 5 days ago
Mr. Ronald Herman Weill, M.A., L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 109 Myrtle St E, Stillwater, MN 55082 Phone: 651-270-9546 | |
Mrs. Carissa Elizabeth Stepan, PSYD, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1751 Tower Dr W Ste 200, Stillwater, MN 55082 Phone: 651-439-2059 Fax: 888-675-8262 | |
Dr. Jeffrey Russell Comins, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1825 Curve Crest Blvd W, Suite 200, Stillwater, MN 55082 Phone: 651-439-2940 Fax: 651-439-2949 | |
Kevyn Dewayne Ziemann, L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1940 Greeley St S, Suite 202c, Stillwater, MN 55082 Phone: 651-491-5602 Fax: 651-748-5773 | |
Ms. Linda Jean Lehmann, M.A., L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 610 Main St N, Suite 200, Stillwater, MN 55082 Phone: 651-327-9002 | |
Melissa Laraby, PSY.D., L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6120 Oren Ave N, Stillwater, MN 55082 Phone: 651-430-0888 Fax: 651-430-0889 | |
Dr. William L. Rush, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1751 Tower Dr W Ste 200, Stillwater, MN 55082 Phone: 651-439-2059 Fax: 888-675-8262 |